Cargando…
A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis
Colorectal cancer represents the second most common cause of cancer-related death. The human A33 transmembrane glycoprotein is a validated tumor-associated antigen, expressed in 95% of primary and metastatic colorectal cancers. Using phage display technology, we generated a human monoclonal antibody...
Autores principales: | Murer, Patrizia, Plüss, Louis, Neri, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999842/ https://www.ncbi.nlm.nih.gov/pubmed/31928310 http://dx.doi.org/10.1080/19420862.2020.1714371 |
Ejemplares similares
-
Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
por: Han, Baek-Sang, et al.
Publicado: (2018) -
Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan
por: Matveev, Andrey L., et al.
Publicado: (2018) -
Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis
Publicado: (1993) -
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014) -
Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP
por: Lin, Ni-Hsuan, et al.
Publicado: (2017)